818 related articles for article (PubMed ID: 23175120)
1. Medulloblastomics: the end of the beginning.
Northcott PA; Jones DT; Kool M; Robinson GW; Gilbertson RJ; Cho YJ; Pomeroy SL; Korshunov A; Lichter P; Taylor MD; Pfister SM
Nat Rev Cancer; 2012 Dec; 12(12):818-34. PubMed ID: 23175120
[TBL] [Abstract][Full Text] [Related]
2. Dissecting the genomic complexity underlying medulloblastoma.
Jones DT; Jäger N; Kool M; Zichner T; Hutter B; Sultan M; Cho YJ; Pugh TJ; Hovestadt V; Stütz AM; Rausch T; Warnatz HJ; Ryzhova M; Bender S; Sturm D; Pleier S; Cin H; Pfaff E; Sieber L; Wittmann A; Remke M; Witt H; Hutter S; Tzaridis T; Weischenfeldt J; Raeder B; Avci M; Amstislavskiy V; Zapatka M; Weber UD; Wang Q; Lasitschka B; Bartholomae CC; Schmidt M; von Kalle C; Ast V; Lawerenz C; Eils J; Kabbe R; Benes V; van Sluis P; Koster J; Volckmann R; Shih D; Betts MJ; Russell RB; Coco S; Tonini GP; Schüller U; Hans V; Graf N; Kim YJ; Monoranu C; Roggendorf W; Unterberg A; Herold-Mende C; Milde T; Kulozik AE; von Deimling A; Witt O; Maass E; Rössler J; Ebinger M; Schuhmann MU; Frühwald MC; Hasselblatt M; Jabado N; Rutkowski S; von Bueren AO; Williamson D; Clifford SC; McCabe MG; Collins VP; Wolf S; Wiemann S; Lehrach H; Brors B; Scheurlen W; Felsberg J; Reifenberger G; Northcott PA; Taylor MD; Meyerson M; Pomeroy SL; Yaspo ML; Korbel JO; Korshunov A; Eils R; Pfister SM; Lichter P
Nature; 2012 Aug; 488(7409):100-5. PubMed ID: 22832583
[TBL] [Abstract][Full Text] [Related]
3. Novel mutations target distinct subgroups of medulloblastoma.
Robinson G; Parker M; Kranenburg TA; Lu C; Chen X; Ding L; Phoenix TN; Hedlund E; Wei L; Zhu X; Chalhoub N; Baker SJ; Huether R; Kriwacki R; Curley N; Thiruvenkatam R; Wang J; Wu G; Rusch M; Hong X; Becksfort J; Gupta P; Ma J; Easton J; Vadodaria B; Onar-Thomas A; Lin T; Li S; Pounds S; Paugh S; Zhao D; Kawauchi D; Roussel MF; Finkelstein D; Ellison DW; Lau CC; Bouffet E; Hassall T; Gururangan S; Cohn R; Fulton RS; Fulton LL; Dooling DJ; Ochoa K; Gajjar A; Mardis ER; Wilson RK; Downing JR; Zhang J; Gilbertson RJ
Nature; 2012 Aug; 488(7409):43-8. PubMed ID: 22722829
[TBL] [Abstract][Full Text] [Related]
4. Medulloblastoma molecular dissection: the way toward targeted therapy.
Remke M; Ramaswamy V; Taylor MD
Curr Opin Oncol; 2013 Nov; 25(6):674-81. PubMed ID: 24076581
[TBL] [Abstract][Full Text] [Related]
5. Wnt/β-catenin signaling inhibits the Shh pathway and impairs tumor growth in Shh-dependent medulloblastoma.
Pöschl J; Bartels M; Ohli J; Bianchi E; Kuteykin-Teplyakov K; Grammel D; Ahlfeld J; Schüller U
Acta Neuropathol; 2014 Apr; 127(4):605-7. PubMed ID: 24531885
[No Abstract] [Full Text] [Related]
6. Medulloblastoma: Molecular Classification-Based Personal Therapeutics.
Archer TC; Mahoney EL; Pomeroy SL
Neurotherapeutics; 2017 Apr; 14(2):265-273. PubMed ID: 28386677
[TBL] [Abstract][Full Text] [Related]
7. Hedgehog signaling drives medulloblastoma growth via CDK6.
Raleigh DR; Choksi PK; Krup AL; Mayer W; Santos N; Reiter JF
J Clin Invest; 2018 Jan; 128(1):120-124. PubMed ID: 29202464
[TBL] [Abstract][Full Text] [Related]
8. Preponderance of sonic hedgehog pathway activation characterizes adult medulloblastoma.
Al-Halabi H; Nantel A; Klekner A; Guiot MC; Albrecht S; Hauser P; Garami M; Bognar L; Kavan P; Gerges N; Shirinian M; Roberge D; Muanza T; Jabado N
Acta Neuropathol; 2011 Feb; 121(2):229-39. PubMed ID: 21107850
[TBL] [Abstract][Full Text] [Related]
9. Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study.
Schwalbe EC; Lindsey JC; Nakjang S; Crosier S; Smith AJ; Hicks D; Rafiee G; Hill RM; Iliasova A; Stone T; Pizer B; Michalski A; Joshi A; Wharton SB; Jacques TS; Bailey S; Williamson D; Clifford SC
Lancet Oncol; 2017 Jul; 18(7):958-971. PubMed ID: 28545823
[TBL] [Abstract][Full Text] [Related]
10. Simplified Molecular Subtyping of Medulloblastoma for Reduced Cost and Improved Turnaround Time.
Shuangshoti S; Tadadontip P; Techavichit P; Thorner PS; Shuangshoti S; Teerapakpinyo C
Appl Immunohistochem Mol Morphol; 2020 Aug; 28(7):538-543. PubMed ID: 31343993
[TBL] [Abstract][Full Text] [Related]
11. Subgroup-specific prognostic signaling and metabolic pathways in pediatric medulloblastoma.
Park AK; Lee JY; Cheong H; Ramaswamy V; Park SH; Kool M; Phi JH; Choi SA; Cavalli F; Taylor MD; Kim SK
BMC Cancer; 2019 Jun; 19(1):571. PubMed ID: 31185958
[TBL] [Abstract][Full Text] [Related]
12. Subgroup-specific structural variation across 1,000 medulloblastoma genomes.
Northcott PA; Shih DJ; Peacock J; Garzia L; Morrissy AS; Zichner T; Stütz AM; Korshunov A; Reimand J; Schumacher SE; Beroukhim R; Ellison DW; Marshall CR; Lionel AC; Mack S; Dubuc A; Yao Y; Ramaswamy V; Luu B; Rolider A; Cavalli FM; Wang X; Remke M; Wu X; Chiu RY; Chu A; Chuah E; Corbett RD; Hoad GR; Jackman SD; Li Y; Lo A; Mungall KL; Nip KM; Qian JQ; Raymond AG; Thiessen NT; Varhol RJ; Birol I; Moore RA; Mungall AJ; Holt R; Kawauchi D; Roussel MF; Kool M; Jones DT; Witt H; Fernandez-L A; Kenney AM; Wechsler-Reya RJ; Dirks P; Aviv T; Grajkowska WA; Perek-Polnik M; Haberler CC; Delattre O; Reynaud SS; Doz FF; Pernet-Fattet SS; Cho BK; Kim SK; Wang KC; Scheurlen W; Eberhart CG; Fèvre-Montange M; Jouvet A; Pollack IF; Fan X; Muraszko KM; Gillespie GY; Di Rocco C; Massimi L; Michiels EM; Kloosterhof NK; French PJ; Kros JM; Olson JM; Ellenbogen RG; Zitterbart K; Kren L; Thompson RC; Cooper MK; Lach B; McLendon RE; Bigner DD; Fontebasso A; Albrecht S; Jabado N; Lindsey JC; Bailey S; Gupta N; Weiss WA; Bognár L; Klekner A; Van Meter TE; Kumabe T; Tominaga T; Elbabaa SK; Leonard JR; Rubin JB; Liau LM; Van Meir EG; Fouladi M; Nakamura H; Cinalli G; Garami M; Hauser P; Saad AG; Iolascon A; Jung S; Carlotti CG; Vibhakar R; Ra YS; Robinson S; Zollo M; Faria CC; Chan JA; Levy ML; Sorensen PH; Meyerson M; Pomeroy SL; Cho YJ; Bader GD; Tabori U; Hawkins CE; Bouffet E; Scherer SW; Rutka JT; Malkin D; Clifford SC; Jones SJ; Korbel JO; Pfister SM; Marra MA; Taylor MD
Nature; 2012 Aug; 488(7409):49-56. PubMed ID: 22832581
[TBL] [Abstract][Full Text] [Related]
13. Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations.
Pugh TJ; Weeraratne SD; Archer TC; Pomeranz Krummel DA; Auclair D; Bochicchio J; Carneiro MO; Carter SL; Cibulskis K; Erlich RL; Greulich H; Lawrence MS; Lennon NJ; McKenna A; Meldrim J; Ramos AH; Ross MG; Russ C; Shefler E; Sivachenko A; Sogoloff B; Stojanov P; Tamayo P; Mesirov JP; Amani V; Teider N; Sengupta S; Francois JP; Northcott PA; Taylor MD; Yu F; Crabtree GR; Kautzman AG; Gabriel SB; Getz G; Jäger N; Jones DT; Lichter P; Pfister SM; Roberts TM; Meyerson M; Pomeroy SL; Cho YJ
Nature; 2012 Aug; 488(7409):106-10. PubMed ID: 22820256
[TBL] [Abstract][Full Text] [Related]
14. The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors.
Northcott PA; Fernandez-L A; Hagan JP; Ellison DW; Grajkowska W; Gillespie Y; Grundy R; Van Meter T; Rutka JT; Croce CM; Kenney AM; Taylor MD
Cancer Res; 2009 Apr; 69(8):3249-55. PubMed ID: 19351822
[TBL] [Abstract][Full Text] [Related]
15. Functional genomics identifies drivers of medulloblastoma dissemination.
Mumert M; Dubuc A; Wu X; Northcott PA; Chin SS; Pedone CA; Taylor MD; Fults DW
Cancer Res; 2012 Oct; 72(19):4944-53. PubMed ID: 22875024
[TBL] [Abstract][Full Text] [Related]
16. Medulloblastoma in the age of molecular subgroups: a review.
Juraschka K; Taylor MD
J Neurosurg Pediatr; 2019 Oct; 24(4):353-363. PubMed ID: 31574483
[TBL] [Abstract][Full Text] [Related]
17. Deep sequencing of WNT-activated medulloblastomas reveals secondary SHH pathway activation.
Iorgulescu JB; Van Ziffle J; Stevers M; Grenert JP; Bastian BC; Chavez L; Stichel D; Buchhalter I; Samuel D; Nicolaides T; Banerjee A; Mueller S; Gupta N; Tihan T; Bollen AW; Northcott PA; Kool M; Pfister S; Korshunov A; Perry A; Solomon DA
Acta Neuropathol; 2018 Apr; 135(4):635-638. PubMed ID: 29435664
[No Abstract] [Full Text] [Related]
18. Developmental phosphoproteomics identifies the kinase CK2 as a driver of Hedgehog signaling and a therapeutic target in medulloblastoma.
Purzner T; Purzner J; Buckstaff T; Cozza G; Gholamin S; Rusert JM; Hartl TA; Sanders J; Conley N; Ge X; Langan M; Ramaswamy V; Ellis L; Litzenburger U; Bolin S; Theruvath J; Nitta R; Qi L; Li XN; Li G; Taylor MD; Wechsler-Reya RJ; Pinna LA; Cho YJ; Fuller MT; Elias JE; Scott MP
Sci Signal; 2018 Sep; 11(547):. PubMed ID: 30206138
[TBL] [Abstract][Full Text] [Related]
19. SMARCA4/Brg1 coordinates genetic and epigenetic networks underlying Shh-type medulloblastoma development.
Shi X; Wang Q; Gu J; Xuan Z; Wu JI
Oncogene; 2016 Nov; 35(44):5746-5758. PubMed ID: 27065321
[TBL] [Abstract][Full Text] [Related]
20. Loss of Pin1 Suppresses Hedgehog-Driven Medulloblastoma Tumorigenesis.
Xu T; Zhang H; Park SS; Venneti S; Kuick R; Ha K; Michael LE; Santi M; Uchida C; Uchida T; Srinivasan A; Olson JM; Dlugosz AA; Camelo-Piragua S; Rual JF
Neoplasia; 2017 Mar; 19(3):216-225. PubMed ID: 28167297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
